Skip to content

Drug interactions

Griseofulvin + Linagliptin

Severity: Moderate

Griseofulvin and Linagliptin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Griseofulvin, an enzyme inducer, is expected to lower linagliptin exposure and could weaken glycemic control. The legacy direction of effect is inconsistent with induction.

What this interaction means in plain words

Griseofulvin and Linagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Griseofulvin belongs to Anti Fungals; Linagliptin belongs to Endocrine.

Evidence level: Low

Why it happens

Induction of CYP3A4 and P-glycoprotein is expected to increase linagliptin clearance.

What to do

Monitor blood glucose and HbA1c, and consider an alternative antidiabetic agent if glycemic control worsens during griseofulvin therapy.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Griseofulvin and Linagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Griseofulvin with Linagliptin?

MediHelp rates the interaction as moderate. Griseofulvin and Linagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Griseofulvin, an enzyme inducer, is expected to lower linagliptin exposure and could weaken glycemic control. The legacy direction of effect is inconsistent with induction.

How serious is the interaction between Griseofulvin and Linagliptin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose and HbA1c, and consider an alternative antidiabetic agent if glycemic control worsens during griseofulvin therapy.

What other medicines interact with Griseofulvin?

MediHelp also lists interactions of Griseofulvin with, for example, Cyclosporine, Cyclosporin, Desogestrel-ethinyl estradiol. The full list is on the Griseofulvin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in